Navigation
banner
Together we Drive the Future

Ocular Diseases Drug Discovery

2017-02-212017-02-202017-02-06
register 3 for the price of 2 with the coupon code rcdvb!


registration button

Ocular Diseases Drug Discovery
 

Dear Colleague,

The 9th Ocular Diseases Drug Discovery Conference is taking place on March 20-21, 2017 in San Diego, CA. We are excited to have top representatives from the industry and academic sectors to discuss technologies and targets that are continually changing the way ocular diseases are treated. Drug delivery is always improving as we look at for better methods to penetrate anterior and poster segments of the eye. Successes in gene therapy and regenerative medicine are proving to be interesting approaches to discuss in detail pre-clinically and clinically. We are gathering leading scientists, researchers, and experts to discuss and collaborate on combating and curing age-related macular degeneration (AMD), dry eye, glaucoma, diabetic macular edema (DME), and other ocular diseases.

Session Topics

  1. Novel Therapeutic Targets for Ocular Diseases
  2. Stem Cell and Gene Therapy for Ocular Diseases
  3. Combination Therapies for Ocular Diseases
  4. Recent Developments in Drug Delivery for Ocular Diseases

Panels

  1. Leveraging CROs to externalize R&D
  2. Business Development and Partnering
  3. Patient Adherence and Compliance

We hope to see you there!

Best regards,
The 2017 Advisory Committee

2017 ADVISORY BOARD MEMBERS
Matthias Birkhoff, Aptar
Hongming Chen, Kalarx
Emmett Cunningham, Clarus Ventures
Rafal Farjo, EyeCRO LLC
Doug Fisher, InterWest
Glenn Noronha, Clearside Biomedical
Donald J. Alcendor, Vanderbilt University
Hongming Chen, Kala Pharmaceuticals